1. Home
  2. SBFM

SBFM

Sunshine Biopharma Inc.

Logo Sunshine Biopharma Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 3:49pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).

Founded: 2006 Country:
Canada
Canada
Employees: N/A City: NEW YORK
Market Cap: 10.1M IPO Year: N/A
Target Price: $2.60 AVG Volume (30 days): 23.2M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.19 EPS Growth: N/A
52 Week Low/High: $0.04 - $1.40 Next Earning Date: 05-08-2024
Revenue: $24,092,787 Revenue Growth: 454.42%
Revenue Growth (this year): 87.97% Revenue Growth (next year): 125.23%

Share on Social Networks: